LYNX-1: A Phase 3 Study of 0.75% Phentolamine Ophthalmic Solution in Subjects with Dim Light Vision Disturbances

Study limitation reported by the research below: “Age distribution and sex breakdown of the study population are not reported in the available abstract, so age group and sex tags are inferred from general trial convention.”